THE GATEWAY TO ORAL HEALTH: Helping the Respiratory-at-Risk Breathe Easier
Entrenched as we are today in the prevalence of COVID-19 and its disturbingly relentless resurgences, it behooves us to consider the viral gateway that has made such devastation possible. Accumulating evidence over the past decade has suggested that oral disorders, particularly periodontal disease may indeed influence the course of respiratory infections.
The gateway? Inflammation creates bacterial plaque which can be aspirated into the lungs where colonization and infection result in airway compromise, increased immunological susceptibility, and full-on obstructive pulmonary infection.
Consequently, eliminating gum disease from this picture could prove to be of significant benefit to countless individuals at risk for COVID-19, COPD, RSV, Pneumonia, et.al.
So much for the problem. Now let’s talk about a way to address respiratory vulnerability at the source: The OraKlenz Oral Care System.
Integrated into a patient’s regular hygiene regimen, the OraKlenz Oral Care System – via the application of patented OraKlenz trays and gel - will measurably eliminate gum disease in a few weeks…while continuing to provide optimum oral and systemic gateway protection when used as part of a regular dentist-prescribed treatment program.
Each individually prescribed OraKlenz treatment tray is made to fit snugly and comfortably over teeth and gum tissue. The treatment margin extends below the pocket depth to ensure targeted effectiveness. A light activating touch infuses the specially formulated OraKlenz Gel – 1.7% hydrogen peroxide with an invigorating mint flavor -- deep into troubled pocket areas for 99.8% treatment efficiency.
For patients faced with the significant threat of exposure to respiratory scourges like Pneumonia, COPD, COVID-19, RSV, et.al. OraKlenz can help in the fight for respiratory health and protection.
Brush. Floss. OraKlenz.
For the dentist, The OraKlenz System fulfills the potential for significant practice expansion and optimal care support. The at-the-source treatment of bacterial proliferation and the subsequent control and protection provided by such a system will definitely come as a breath of fresh air to a wide range of patients -- those struggling with chronic halitosis and/or gum disease; those faced with the possibility of oral re-infection; those at risk for a recurrence of COVID-19, RSV or a multitude of more serious systemic conditions.
WANT TO KNOW MORE?
VISIT OUR WEBSITE: www.SMLglobal.com
https://www.nature.com/articles/sj.bdj.2017.315
https://www.dentistrytoday.com/sp-1445906364/